{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:42:17Z","timestamp":1792741337743,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.vaccine.2023.04.025","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T15:32:04Z","timestamp":1696606324000},"page":"S176-S179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S2","title":["Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasis"],"prefix":"10.1016","volume":"41","author":[{"given":"Peter J.","family":"Hotez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Philipp","family":"Puchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.025_b0005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.025_b0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/trstmh\/trab015","article-title":"The history of the neglected tropical disease movement","volume":"115","author":"Molyneux","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.04.025_b0015","first-page":"1570","article-title":"Rescuing the bottom billion through control of neglected tropical diseases","volume":"373","author":"Hotez","year":"2009","journal-title":"LancetLond Engl"},{"key":"10.1016\/j.vaccine.2023.04.025_b0020","first-page":"1080","article-title":"A handful of \u201cantipoverty\u201d vaccines exist for neglected diseases, but the world\u2019s poorest billion people need more","volume":"30","author":"Hotez","year":"2011","journal-title":"HealthAff Proj Hope"},{"key":"10.1016\/j.vaccine.2023.04.025_b0025","year":"2020","journal-title":"Inst Health Metr Eval"},{"key":"10.1016\/j.vaccine.2023.04.025_b0030","unstructured":"GBD 2019 Cause and Risk Summaries. Inst Health Metr Eval n.d. https:\/\/www.healthdata.org\/results\/gbd_summaries\/2019 [accessed November 7, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.025_b0035","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4269\/ajtmh.20-0503","article-title":"Maternal hookworm infection and its effects on maternal health: a systematic review and meta-analysis","volume":"103","author":"Ness","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.04.025_b0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4269\/ajtmh.2007.77.88","article-title":"Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control","volume":"77","author":"Brooker","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.04.025_b0045","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMp1914709","article-title":"Female genital schistosomiasis","volume":"381","author":"Hotez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.025_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.04.025_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old world cutaneous leishmaniasis and refugee crises in the Middle East and North Africa","volume":"10","author":"Du","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.04.025_b0060","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13071-016-1743-7","article-title":"A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries","volume":"9","author":"Al-Salem","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2023.04.025_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pt.2018.11.001","article-title":"Neglected tropical diseases and mental health: progress, partnerships, and integration","volume":"35","author":"Bailey","year":"2019","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2023.04.025_b0070","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.vaccine.2016.03.018","article-title":"Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting","volume":"34","author":"Bartsch","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.025_b0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13071-022-05178-x","article-title":"Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni","volume":"15","author":"Kura","year":"2022","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2023.04.025_b0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vaccine.2012.11.032","article-title":"The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas","volume":"31","author":"Bacon","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.025_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.2012.10-0415","article-title":"The economic value of a visceral leishmaniasis vaccine in Bihar state","volume":"86","author":"Lee","year":"2012","journal-title":"India Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.04.025_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004922","article-title":"The global economic and health burden of human hookworm infection","volume":"10","author":"Bartsch","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.04.025_b0095","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.vaccine.2009.09.047","article-title":"Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.025_b0100","first-page":"927","article-title":"The potential health care costs and resource use associated With COVID-19 in the United States","volume":"39","author":"Bartsch","year":"2020","journal-title":"HealthAff Proj Hope"},{"key":"10.1016\/j.vaccine.2023.04.025_b0105","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4269\/ajtmh.21-1026","article-title":"Tropical infectious diseases: still here, still raging, still killing","volume":"105","author":"Hotez","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.04.025_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101053","article-title":"Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic","volume":"39","author":"Hotez","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2023.04.025_b0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/vaccines10050713","article-title":"MosquirixTM RTS, S\/AS01 vaccine development, immunogenicity, and efficacy","volume":"10","author":"Nadeem","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2023.04.025_b0120","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1080\/21645515.2019.1629254","article-title":"Running the Gauntlet\u201d: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a \u201cCall to Action","volume":"15","author":"Bottazzi","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2023.04.025_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009742","article-title":"Human leishmaniasis vaccines: use cases, target population and potential global demand","volume":"15","author":"Malvolti","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.04.025_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010471","article-title":"Estimating the global demand curve for a leishmaniasis vaccine: a generalisable approach based on global burden of disease estimates","volume":"16","author":"Mohan","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.04.025_b0135","doi-asserted-by":"crossref","first-page":"taac063","DOI":"10.1093\/jtm\/taac063","article-title":"COVID-19 vaccines: the imperfect instruments of vaccine diplomacy","author":"Hotez","year":"2022","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2023.04.025_b0140","doi-asserted-by":"crossref","unstructured":"Gordon SB, Rylance J, Luck A, Jambo K, Ferreira DM, Manda-Taylor L, et al. A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi. Wellcome Open Res 2017;2:70. 10.12688\/wellcomeopenres.12256.1.","DOI":"10.12688\/wellcomeopenres.12256.1"},{"key":"10.1016\/j.vaccine.2023.04.025_b0145","unstructured":"Developing Country Vaccine Manufacturers Network. Protecting people from global diseases n.d. https:\/\/dcvmn.org\/ [accessed November 7, 2022]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:30:44Z","timestamp":1759404644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23004176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":29,"alternative-id":["S0264410X23004176"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}